Issue |
J Extra Corpor Technol
Volume 52, Number 3, September 2020
|
|
---|---|---|
Page(s) | 196 - 202 | |
DOI | https://doi.org/10.1051/ject/202052196 | |
Published online | 15 September 2020 |
Original Article
Extracorporeal Membrane Oxygenation during Percutaneous Coronary Intervention in Patients with Coronary Heart Disease
* State Institution “Heart Institute of the Ministry of Health of Ukraine”, Kyiv, Ukraine;
† Department of Anesthesiology and Intensive Care, NMAPE Named After P.L. Shupyk, Kyiv, Ukraine
‡ Department of Cardiosurgery, X-ray and Extracorporeal Technologies, NMAPE Named After P.L. Shupyk, Kyiv, Ukraine
Address correspondence to: Stepan R. Maruniak, PhD Student, State Institution “Heart Institute of the Ministry of Health of Ukraine”, Bratyslavska str. 5A, Kyiv 22019, Ukraine. E-mail: maruniak.stepan@gmail.com
Received:
19
November
2019
Accepted:
16
July
2020
Extracorporeal membrane oxygenation (ECMO) has become an effective method in the treatment of adults and children with severe cardiac and pulmonary dysfunction that is resistant to conventional therapy. The aim of this article was to summarize an experience of ECMO usage for cardiac dysfunction, which develops in patients with coronary heart disease (CHD) during percutaneous transluminal coronary angioplasty. The study comprised a retrospective, single-center analysis of 23 patients with CHD (19 men and four women, average age 65.7 ± 12.3 years), who undertook the ECMO technique during percutaneous transluminal coronary angioplasty. A total of 13 (56.52%) patients died directly in the hospital, or 30 days after a discharge. Independent predictors of fatal outcomes were diabetes mellitus (odds ratio [OR] = 17.58; 95% confidence interval [CI] = 6.47–47.48; p = .00125), chronic renal failure (CRF) (OR = 20.81; 95% CI = 5.95–72.21; p = .00014), and damage to the right coronary artery (RCA) (OR = 25.51; 95% CI = 8.27–79.12; p = .00013). For deceased patients, the “no reflow” phenomenon was indicated in a larger percentage of cases (23.1% in the group of deceased, vs. 10% in the group of survivors). A routine connection to ECMO before the occurrence of cardiac events was significantly more often used in the group of survived patients (90% of cases) than in the deceased (p = .0000001). Diabetes mellitus, CRF, and damage to the RCA were independent predictors of mortality during percutaneous transluminal coronary angioplasty in patients with CHD. The routine use of ECMO in high-risk patients with percutaneous transluminal coronary angioplasty was a positive prognostic factor of patient survival.
Key words: extracorporeal membrane oxygenation / myocardial infarction / percutaneous transluminal coronary angioplasty / cardiogenic shock
© 2020 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.